Normal human immunoglobulin suppresses experimental myasthenia gravis in SCID mice

European Journal of Immunology

Volumn 29, Issue 8, 1999, Pages 2436-2442

  Vassilev, Tchavdar ^a,e   Yamamoto, Maria ^b   Aissaoui, Abderrahim ^c   Bonnin, Emmanuelle ^a   Berrih Aknin, Sonia ^c   Kazatchkine, Michel D ^a   Kaveri, Srinivas V ^a,d  

^a INSERM   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^d HÔPITAL BROUSSAIS   (France)

^e INSTITUTE OF MICROBIOLOGY   (Bulgaria)

Author keywords

Autoimmunity; IgM; Immunomodulation; Myasthenia gravis; SCID

Indexed keywords

CHOLINERGIC RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; DIAPHRAGM; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREGULATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; MYASTHENIA GRAVIS; NONHUMAN; PRIORITY JOURNAL; THYMOCYTE;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSION; MICE; MICE, SCID; MOTOR ENDPLATE; MYASTHENIA GRAVIS; RATS; RECEPTORS, CHOLINERGIC;

EID: 0032767113     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199908)29:08<2436::AID-IMMU2436>3.0.CO;2-9     Document Type: Article

References (38)

1. Christensen, P. B., Jensen, T. S., Tsiropoulos, I., Sorensen, T., Kjaer, M., Hojer-Pedersen, E., Rasmussen, M. J. and Lehfeldt, E., Associated autoimmune diseases in myasthenia gravis. A population-based study. Acta Neurol. Scand. 1995. 91: 192-195.
2. Vincent, A. and Newsom-Davis, J., Acetylcholine receptor antibody as a diagnosis test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J. Neurol. Neurosurg. Psychiatry 1985. 48: 1246-1252.
3. Soliven, B. C., Lange, D. J., Penn, A. S., Younger, D., Jaretzki-III, A., Lovelace, R. E. and Rowland, L. P., Seronegative myasthenia gravis. Neurology 1988. 38: 514-517.
4. Van-de-Velde, R. L. and Friedman, N. B., The thymic "myoidzellen" and myasthenia gravis. Am. J. Pathol. 1966. 198: 287-288.
5. Wekerle, H., Paterson, B., Ketelsen, U. P. and Feldmann, M., Striated muscle fibres differentiate in monolayer cultures of adult thymus reticulum. Nature 1975. 256: 493-494.
6. Wekerle, H. and Ketelsen, U. P., Intrathymic pathogenesis and dual genetic control of myasthenia gravis. Lancet 1977. 1: 678-680.
7. Kao, I. and Drachman, D. B., Thyimic muscle cells bear acetylcholine receptors: possible relation to myasthenia gravis. Science 1977. 195: 74-75.
8. Sharshar, T., Lacroix-Desmazes, S., Mouthon, L., Kaveri, S. V., Gajdos, P. and Kazatchkine, M. D., Selective impairment of serum antibody repertoires toward muscle and thymus antigens in patients with seronegative and seropositive myasthenia gravis. Eur. J. Immunol. 1998. 28: 2344-2354.
9. Martino, G., DuPont, B. L., Wollmann, R., Bongiovanni, P., Anastasi, J., Quintans, J., Arnason, B. G. W. and Grimaldi, L. M. E., The human-severe combined immunodeficiency myasthenic mouse model: A new approach forthe study of myasthenia gravis. Ann. Neurol. 1993. 34: 48-56.
10. Schönbeck, S., Padberg, F., Marx, A., Hohlfeld, R. and Wekerle, H., Transplantation of myasthenia gravis thymus to SCID mice. Ann. N. Y. Acad. Sci. 1993. 681: 66-73.
11. Spuler, S., Marx, A., Kirchner, T., Hohlfeld, R. and Wekerle, H., Myogenesis in thymic transplants in the severe combined immunodeficient mouse model of myasthenia gravis. Am. J. Pathol. 1994. 145: 766-770.
12. Dalakas, M. C., Intravenous immune globulin therapy for neurologic diseases. Ann. Intern. Med. 1997. 126: 721-730.
13. Dwyer, J. M., Manipulating the immune system with immune globulin. N. Engl. J. Med. 1992. 326: 107-116.
14. Kazatchkine, M. D., Dietrich, G., Hurez, V., Ronda, N., Bellon, B., Rossi, F. and Kaveri, S. V., V Region-mediated selection of autoreactive repertoires by intravenous immunoglobulin (IVIg). Immunol. Rev. 1994. 139: 79-107.
15. Hughes, R., Plasma exchange versus intravenous immunoglobulin for Guillain-Barré syndrome. Jpn. J. Apheresis. 1996. 15: S12.
16. Voltz, R. and Hohlfeld, R., The use of intravenous immunoglobulines in the treatment of neuromuscular disorders. Curr. Opin. Neurol. 1996. 9: 360-366.
17. Stangel, M., Hartung, H. P., Marx, P. and Gold, R., Intravenous immunoglobulin treatment of neurological autoimmune diseases. J. Neurol. Sci. 1998. 153: 203-214.
18. van-der Meche, F. G. and van Doom, P. A., Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies. Ann. Neurol. 1995. 37: S14-S31.
19. Comi, G., Nemni, R., Amadio, S., Galardi, G. and Leocani, L., Intravenous immunoglobulin treatment in multifocal motor neuropathy and other chronic immune-mediated neuropathies. Mult. Scler. 1997. 3: 93-97.
20. Sussman, G. L. and Pruzanski, W., Treatment of inflammatory myopathy with intravenous gamma globulin. Curr. Opin. Rheumatol. 1995. 7: 510-515.
21. Gajdos, P., Intravenous immunoglobulin in myasthenia gravis. Clin. Exp. Immunol. 1994. 97 (suppl. 1): 49-51.
22. Gajdos, P., Chevret, S., Clair, B., Tranchant, C. and Chastang, C., Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group. Ann. Neurol. 1997. 41: 789-796.
23. Jongen, J. L., van-Doorn, P. A. and van-der-Meche, F. G., High-dose intravenous immunoglobulin therapy for myasthenia gravis. J. Neurol. 1998. 245: 26-31.
24. Herrmann, D. N., Carney, P. R. and Wald, J. J., Juvenile myasthenia gravis: treatment with immune globulin and thymectomy. Pediatr. Neurol. 1998. 18: 63-66.
25. Liblau, R., Gajdos, P., Bustarret, F. A., Habib, R. E., Bach, J. F. and Morel, E., Intravenous gammaglobulin in myasthenia gravis: Interaction with anti-acetylcholine receptor autoantibodies. J. Clin. Immunol. 1991. 11: 128-131.
26. Hurez, V., Kazatchkine, M. D., Ramanathan, S., Basuyaux, B., Pashov, A., Vassilev, T., De-Kozak, Y., Bellon, B. and Kaveri, S. V., Pooled normal human polyspecific IgM contains neutralyzing antiidiotypes to IgG autoantibodies of autoimmune patients and protects from autoimmune disease. Blood 1997. 70: 4004-4013.
27. Schönbeck, S., Padberg, F., Hohlfeld, R. and Wekerle, H., Transplantation of thymic autoimmune microenvironment to severe combined immunodeficient mice. A new model of myasthenia gravis. J. Clin. Invest. 1992. 90: 245-250.
28. Spuler, S., Sarropoulos, A., Marx, A., Hohlfeld, R. and Wekerle, H., Thymoma-assocoated myasthenia gravis. Transplantation of thymoma and extrathymomal thymic tissue into SCID mice. Am. J. Pathol. 1996. 148: 1359-1365.
29. Wekerle, H., Hohlfeld, R., Ketelsen, U. P., Kalden, J. R. and Kalies, I., Thymic myogenesis, T lymphocytes and the pathogenesis of myasthenia gravis. Ann. N. Y. Acad. Sci. 1981. 377: 455-465.
30. Rossi, F. and Kazatchkine, M. D., Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig. J. Immunol. 1989. 143: 4104-4109.
31. Rossi, F., Dietrich, G. and Kazatchkine, M. D., Antiidiotypes against autoantibodies in normal immunoglobulins: Evidence for network regulation of human autoimmune responses. Immunol. Rev. 1989. 110: 135-149.
32. Adib, M., Ragimbeau, J., Avrameas, S. and Ternynck, T., IgG autoantibody activity in normal mouse serum is controlled by IgM. J. Immunol. 1990. 145: 3807-3813.
33. Hurez, V., Kaveri, S. V. and Kazatchkine, M. D., Expression and control of the natural autoreactive IgG repertoire in normal human serum. Eur. J. Immunol. 1993. 23: 783-789.
34. Mouthon, L., Nobrega, A., Nicolas, N., Kaveri, S. V., Barreau, C., Coutinho, A. and Kazatchkine, M. D., Invariance and restriction towards a limited set of self-antigens characterize neonatal IgM antibody repertoires and prevail in autoreactive repertoires of healthy adults. Proc. Natl. Acad. Sc. USA 1995. 92: 3839-3843.
35. Lindstrom, J. M., An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis. Clin. Immunol. Immunopathol. 1997. 7: 36-43.
36. Vernet-Garabedian, B., Morel, E. and Bach, J. F., Heterogeneity of antibodies directed against the bungaro-toxin binding site on human acetylcholine receptor and myasthenia gravis severity. J. Neuroimmunol. 1986. 12: 65-74.
37. Martino, G., Twaddle, G., Brambilla, E. and Grimaldi, L, Detection of anti-acetylcholine receptor antibody by an ELISA using human receptor from a rhabdomyosarcoma cells line. Acta Neurol. Scand. 1994. 89: 18-22.
38. Wilson, S., Vincent, A. and Newsom-Davis, J., Acethylcholine receptor turnover in mice with passively transfered myasthenia gravis. I. Receptor degradation. J. Neurol. Neurosurg. Psychiatry 1983. 46: 377-382.